| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alternating Therapy With Osimertinib and Afatinib Blockades EGFR Secondary Mutation in EGFR-Mutant Lung Cancer: A Single-Arm Phase II Trial
|
Yonesaka, Kimio
|
|
|
24 |
6 |
p. 519-527.e4
|
artikel
|
| 2 |
Association of Molecular Profiles and Mutational Status With Distinct Histological Lung Adenocarcinoma Subtypes. An Analysis of the LACE-Bio Data
|
Ashok Kumar, Prashanth
|
|
|
24 |
6 |
p. 528-540
|
artikel
|
| 3 |
Authors’ Response to “Letter to the Editor” Submitted by S. Wang and W. Liu (re: “Retrospective Study to Examine Prognostic Value of C-Reactive Protein in Patients With Surgically Resectable Non-Small-Cell Lung Cancer”
|
Azzoli, Christopher
|
|
|
24 |
6 |
p. e197
|
artikel
|
| 4 |
Brief Report: Predictive value of PD-L1 Expression in non–Small-Cell Lung Cancer - Should we Set the Bar Higher for Monotherapy?
|
Nikolic, Nikola
|
|
|
24 |
6 |
p. e214-e218
|
artikel
|
| 5 |
Brief Report: Second-line treatment outcomes in patients with advanced NSCLC previously treated with first-line immunotherapy regimens
|
Tompkins, William P.
|
|
|
24 |
6 |
p. 558-562.e2
|
artikel
|
| 6 |
Characteristics of Patients With Second Primary Lung Cancer Following Breast Cancer: A Retrospective Descriptive Study
|
Wang, Kevin Yu
|
|
|
24 |
6 |
p. e198-e204
|
artikel
|
| 7 |
Clinical Outcomes With Pembrolizumab-Based Therapies in Recurrent/Refractory NSCLC After Chemoradiation and Consolidative Durvalumab
|
Delasos, Lukas
|
|
|
24 |
6 |
p. e205-e213
|
artikel
|
| 8 |
Comments on “Retrospective Study to Examine Prognostic Value of C-Reactive Protein in Patients With Surgically Resectable Non–Small Cell Lung Cancer”
|
Wang, Sujuan
|
|
|
24 |
6 |
p. e195-e196
|
artikel
|
| 9 |
Continuous vs. Fixed 2-year Duration Immune Checkpoint Inhibitor Treatment of Patients With Non–Small Cell Lung Cancer: A Single Institution Database Analysis
|
Kobayashi, Haruki
|
|
|
24 |
6 |
p. 498-506.e3
|
artikel
|
| 10 |
Differentiation Between Heterogeneous GGN and Part-Solid Nodule Using 2 D Grayscale Histogram Analysis of Thin-Section CT Image
|
Koike, Hirofumi
|
|
|
24 |
6 |
p. 541-550
|
artikel
|
| 11 |
Editorial Board
|
|
|
|
24 |
6 |
p. A1
|
artikel
|
| 12 |
Geographic Origin may Affect Outcomes for Hispanic Patients with Non-Small Cell Lung Cancer in the United States
|
Bilani, Nadeem
|
|
|
24 |
6 |
p. e219-e225
|
artikel
|
| 13 |
Impact of the Number of Harvested Lymph Nodes on Long-Term Survival in Node-Negative Non–Small-Cell Lung Cancer: Based on Clinical Stage But Not Pathological Stage
|
Yang, Mu-Zi
|
|
|
24 |
6 |
p. e226-e235
|
artikel
|
| 14 |
KRAS G12C Mutant Non–Small Cell Lung Cancer Linked to Female Sex and High Risk of CNS Metastasis: Population-based Demographics and Survival Data From the National Swedish Lung Cancer Registry
|
Isaksson, Johan
|
|
|
24 |
6 |
p. 507-518
|
artikel
|
| 15 |
MET Exon 14 Skipping in NSCLC: A Systematic Literature Review of Epidemiology, Clinical Characteristics, and Outcomes
|
Mazieres, Julien
|
|
|
24 |
6 |
p. 483-497
|
artikel
|
| 16 |
Rationale and Design of the Phase II ANTELOPE Study of Atezolizumab, Carboplatin and nab-Paclitaxel vs. Pembrolizumab, Platinum and Pemetrexed in TTF-1 Negative, Metastatic Lung Adenocarcinoma (AIO-TRK-0122)
|
Frost, Nikolaj
|
|
|
24 |
6 |
p. 568-572
|
artikel
|
| 17 |
Short Report of a Phase II Trial of Nintedanib in Recurrent Malignant Pleural Mesothelioma (MPM)
|
Wozniak, Antoinette J.
|
|
|
24 |
6 |
p. 563-567
|
artikel
|
| 18 |
Table of Contents
|
|
|
|
24 |
6 |
p. A3-A5
|
artikel
|
| 19 |
The 8th Edition TNM Stage Reclassification of T4 Non-Small Cell Lung Cancer: A Granular Examination of Short and Long-Term Outcomes
|
Tankel, James
|
|
|
24 |
6 |
p. 551-557
|
artikel
|
Tijdschrift beschrijving